TeraImmune, Inc. is a biotechnology company that develops innovative immune-cell therapies. Our investigational technology programs regulatory T (Treg) cells to recognize and suppress unwanted immune reactions. Increased selectivity of Treg cells with target-specific receptors can enable to suppress the unwanted immune reactions without side effects in the patients with autoimmune diseases.
The body's immune system protects humans from disease and infection. When someone is affected by an autoimmune disease, the immune system attacks healthy cells in the body by mistake. Autoimmune diseases can affect many parts of the body.